IL22 and inflammatory bowel disease: While intestinal CD4+ T cells represented the main source of local IL-22 in Crohn’s disease patients, IL-22-producing NKp44+ ILCs were predominant in the gut of AS patients (82), highlighting differences between the etiology of IBD and SpA-associated intestinal inflammation.